Conceptus(R) Announces 10-Year Commercial Data for Essure(R) at 40th AAGL Global Congress of Minimally Invasive Gynecology
November 08, 2011 09:00 ET
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
Conceptus(R) to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
November 07, 2011 17:15 ET
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
Conceptus(R) Reports Third Quarter Financial Results
October 25, 2011 16:05 ET
|
Conceptus, Inc.
Domestic physician penetration metrics solid
Updates 2011 financial guidance
MOUNTAIN VIEW, Calif., Oct. 25, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS),developer of the...
Conceptus(R) Wins Favorable Verdict in Patent Litigation Against Hologic; Jury Awards Conceptus $18.8 Million
October 17, 2011 19:32 ET
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Oct. 17, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
Conceptus(R) Acquires All Distribution Rights Related to the Essure(R) Procedure in the Netherlands
October 04, 2011 16:16 ET
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Oct. 4, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
Conceptus(R) to Hold Third Quarter Financial Results Conference Call on October 25, 2011
October 04, 2011 16:15 ET
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Oct. 4, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
Conceptus(R) Enters Into New Revolving Line of Credit Agreement With Wells Fargo Bank, N.A.
August 26, 2011 09:00 ET
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Aug. 26, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
Conceptus(R) to Present at the Stifel Nicolaus 2011 Healthcare Conference
August 24, 2011 17:30 ET
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Aug. 24, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
Conceptus(R) Announces FDA Approval to Remove Nickel Contraindication From the Essure Procedure Instructions
August 04, 2011 16:10 ET
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS),developer of the Essure® procedure, the most effective non-surgical permanent birth control method available,...
Conceptus(R) Reports Second Quarter Financial Results
August 04, 2011 16:05 ET
|
Conceptus, Inc.
Reports Net Sales of $33.8 Million, 27% Sequential Growth
Expands Hysteroscopic Sterilization Market With Strong New-Physician Penetration Metrics
Updates Financial...